CSB-321

· Cytosite Biopharma Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CSB-321, covering 2025-07-09 to 2025-07-09. Get the full timeline:

Most recent: Clinical Trial Update: CSB-321 Ph 1 in Immunotherapy for the Treatment of Cancer [Phase 1]